【摘要】：1.研究目的及意義 角膜組織沒有血管的透明組織。維持其透明性的一個(gè)很重要的原因是它沒有血管。在感染、外傷、免疫反應(yīng)、排斥反應(yīng)、佩戴角膜接觸鏡、堿燒傷、基質(zhì)潰瘍、角膜緣干細(xì)胞病變等病理情況下,從角膜緣血管網(wǎng)形成的新生血管逐漸侵入角膜,從而形成角膜新生血管(corneal neovascularization, CNV)。誠然,CNV在感染清除、傷口愈合等方面具有一定的積極作用。但是,CNV導(dǎo)致角膜的透明性降低,從而嚴(yán)重的影響視力,另外,CNV可破壞角膜正常微環(huán)境,使眼前節(jié)生理性的免疫豁免消失,因而成為角膜移植排斥反應(yīng)的高危因素。因此,針對角膜新生血管的治療業(yè)已成為眼科的研究熱點(diǎn)。近年來的研究證實(shí),血管抑素(angiostatin, AS)存在著明確的抗角膜新生血管形成的作用,角膜上皮細(xì)胞被證明可以分泌血管抑素,但在角膜受到損傷后分泌減少。另外,血管抑素被證實(shí)通過病毒載體或者局部運(yùn)用可以抑制角膜新生血管形成。但相關(guān)作用機(jī)制研究的不足,影響著其最終運(yùn)用于臨床的進(jìn)程。因此,闡明血管抑素抗角膜新生血管形成的機(jī)制,勢必為其臨床運(yùn)用奠定堅(jiān)實(shí)的基礎(chǔ),并產(chǎn)生巨大的社會和經(jīng)濟(jì)效益。 2.研究方法 眾所周知,蛋白質(zhì)是一類重要的生物大分子,是生命活動的主要承擔(dān)者。在蛋白質(zhì)組(proteome)概念提出以后,蛋白質(zhì)組學(xué)的研究取得了可喜的發(fā)展。相比較傳統(tǒng)的只針對單一蛋白質(zhì)的研究,蛋白質(zhì)組學(xué)更加注重的是參與特定生理或病理狀態(tài)的所有蛋白質(zhì)種類及其與周圍環(huán)境(分子)的關(guān)系。隨著相關(guān)實(shí)驗(yàn)技術(shù)的發(fā)展,目前已有可能對細(xì)胞在不同生理或病理?xiàng)l件下蛋白質(zhì)表達(dá)的異同,相關(guān)蛋白質(zhì)的分類和鑒定,尤其是蛋白質(zhì)之間相互作用和蛋白質(zhì)的功能進(jìn)行探討。因此,本課題擬以堿燒傷制備的角膜新生血管為基礎(chǔ),局部施加血管抑素,將角膜組織進(jìn)行二維電泳,分離蛋白質(zhì)并進(jìn)行染色,凝膠圖像分析系統(tǒng)對蛋白質(zhì)點(diǎn)進(jìn)行定量分析,從而明確局部施加血管抑素在抗角膜新生血管形成過程中的差異表達(dá)蛋白,進(jìn)一步地,對其進(jìn)行質(zhì)譜分析,從而得到相關(guān)蛋白質(zhì)的定性數(shù)據(jù)。 3.研究內(nèi)容和過程 (1)實(shí)驗(yàn)動物及分組：本實(shí)驗(yàn)采用的是32只新西蘭大白兔(購自南方醫(yī)科大學(xué)動物中心),實(shí)驗(yàn)動物分為三組,A組為空白對照組：8只新西蘭兔不做任何處理；B組為燒傷組：12只新西蘭兔采用堿燒傷的方法建立角膜新生血管模型,術(shù)后第1天開始局部生理鹽水點(diǎn)眼,每日3次,直至取角膜標(biāo)本；C組為治療組：12只新西蘭兔采用同樣方法建立角膜新生血管模型后,術(shù)后第1天開始局部用30μg/ml血管抑素(AS)點(diǎn)眼,每日3次,直至取角膜標(biāo)本。 (2)角膜新生血管模型制作：堿燒傷法制備角膜新生血管模型：氯胺酮25mg/kg及氯丙嗪25mg/kg肌注新西蘭兔全身麻醉,0.5%丁卡因表面麻醉,置開瞼器充分暴露眼表,將浸有1.5mol/LNaOH液的10mm圓形濾紙片置于眼表中央,1.5min后取下,用50m1生理鹽水沖洗眼表,滴妥布霉素眼液后涂妥布霉素眼膏。 (3)角膜新生血管的觀察：術(shù)后觀察角膜的新生血管,第16日使用裂隙燈(蘇州66生產(chǎn)YZ5T型號)照相。角膜新生血管的檢測：測量血管長度,以連續(xù)彎曲度小、新生血管朝向角膜混濁中心生長的最長血管為準(zhǔn),并計(jì)算角膜新生血管生長面積(A),按公式A=C/12×3.1416[r2-(r-1)2]。C為Nv累及角膜的圓周鐘點(diǎn)數(shù),1為新生血管從角膜緣深入角膜的長度,r為兔角膜半徑,設(shè)為定值7mm。 (4)標(biāo)本取材及全蛋白提取：術(shù)后3w取材。標(biāo)本離體后迅速置入5ml凍存管,于液氮速凍后置入-80℃超低溫冰箱保存?zhèn)溆谩Ｈ?80℃保存的組織塊,迅速研磨至細(xì)粉末狀,加入裂解液勻漿、離心。采用Bradford定量法,計(jì)算樣品蛋白質(zhì)濃度。 (6)雙向凝膠電泳(2-DE)：第一向(IPG-IEF)根據(jù)蛋白質(zhì)等電點(diǎn)的不同進(jìn)行等電聚焦,第二向(SDSPAGE)根據(jù)蛋白質(zhì)相對分子質(zhì)量大小分離樣品,雙向電泳后才用EMBL銀染。 (7)圖像分析和差異蛋白選�。簩€y染后的2-DE膠圖掃描入電腦。應(yīng)用ImageMaster2D軟件分析每一張凝膠圖像,計(jì)算圖譜中所有蛋白質(zhì)點(diǎn)的蛋白質(zhì)相對含量,找出三塊膠中均出現(xiàn),并且有差異的蛋白。 (8)質(zhì)譜分析：切取有差異的蛋白質(zhì)點(diǎn),行脫色、酶解、萃取樣品,利用美國ABI4700MALDI-TOF-TOF質(zhì)譜儀進(jìn)行質(zhì)譜分析。UV波長為355nm,重復(fù)速率為200HZ,加速電壓為20000V,最優(yōu)質(zhì)量分辨率為1500Da。掃描質(zhì)量范圍為700-3200Da,收集信號。胰酶自切峰為內(nèi)標(biāo)校正質(zhì)譜儀。所有實(shí)驗(yàn)樣品的質(zhì)譜圖均以用默認(rèn)模式獲得。 (9)數(shù)據(jù)庫檢索：利用軟件Mascot distiller過濾基線峰、識別信號峰。利用Matrixscience公司的Mascot軟件搜索哺乳動物數(shù)據(jù)庫,尋找匹配的相關(guān)蛋白質(zhì),同時(shí)查詢其功能,來明確鑒定的蛋白質(zhì)為何種蛋白質(zhì)。查詢條件：(1)肽質(zhì)量控制在800-4000Da。(2)表觀PI與表觀Mr的誤差范圍：無限制。(3)肽片段分子量最大容許誤差控制在±50ppm。(4)酶解片段不完全選擇為1-2個(gè)。(5)物種來源選擇(哺乳動物)。(6)離子選擇MH和monoisotopic。(7)固定修飾為半胱氨酸碘乙酰胺化(Carbamidomethy1),可變修飾為蛋氨酸氧化(Oxsidation)。 4.主要結(jié)果 (1)成功建立兔角膜新生血管模型。 (2)兔角膜堿燒傷后第16天,血管抑素作用組(C組)的新生血管面積37.62+9.65mm2,對照組(B組)面積46.77+8.98mm2,采用兩獨(dú)立樣本t檢驗(yàn),并用SPSS13.0軟件進(jìn)行分析,P0.05,證明血管抑素對角膜新生血管有抑制作用。 (3)各樣本進(jìn)行雙向電泳后,將A、C兩組與B組進(jìn)行比較,檢測到13個(gè)差異蛋白點(diǎn)。 (4)差異蛋白鑒定：通過質(zhì)譜分析和數(shù)據(jù)庫檢索,成功鑒定了這13個(gè)蛋白(有兩個(gè)蛋白的鑒定結(jié)果顯示為同一蛋白)。其中B組較A、C組均明顯降低的有6種蛋白：白蛋白前體、熱休克蛋白A8、丙酮酸激酶、βB3-晶體蛋白、視黃醛蛋白1以及一個(gè)尚未命名的蛋白；B組較A、C組均明顯升高的有6種蛋白：網(wǎng)鈣結(jié)合蛋白3、角蛋白14、肌動蛋白11、免疫球蛋白λ鏈,免疫球蛋白K鏈、結(jié)合珠蛋白。 5.主要結(jié)論 在過去的幾十年中,在腫瘤、角膜新生血管及其他新生血管性疾病中,抗血管治療通過局部運(yùn)用或者基因載體方式得到了巨大的發(fā)展,并且在這次實(shí)驗(yàn)中,我們發(fā)現(xiàn)經(jīng)過堿燒傷的兔角膜在局部滴用血管抑素后,新生血管明顯減少,這就證明了血管抑素可以有效的抑制血管內(nèi)皮細(xì)胞的遷移及增殖,并且誘導(dǎo)這些細(xì)胞凋亡。為了了解血管抑素抗血管作用的機(jī)理,通過蛋白組學(xué),我們發(fā)現(xiàn)角膜堿燒傷后局部應(yīng)用血管抑素,可以抑制燒傷后升高的蛋白,如角蛋白14、網(wǎng)鈣蛋白3、結(jié)合珠蛋白,這些蛋白都參與了新生血管的形成。血管抑素同時(shí)可以恢復(fù)燒傷后降低的蛋白,如晶體蛋白、視黃醇結(jié)合蛋白、白蛋白前體、丙酮酸激酶、HSPA8蛋白,這些蛋白與角膜上皮修復(fù)、能量代謝、蛋白合成有關(guān)。在下一步的研究中,血管抑素對各種蛋白含量的動態(tài)變化是我們研究的方向。
[Abstract]:1. purpose and significance of the study
Corneal tissue is a transparent tissue without blood vessels. One important reason for maintaining its transparency is that it has no blood vessels. In pathological conditions such as infection, trauma, immune response, rejection, wearing contact lenses, alkali burns, stromal ulcers, limbal stem cell lesions, neovascularization from the limbal vascular network gradually invades the cornea, from Certainly, CNV plays a positive role in clearance of infection and wound healing. However, CNV leads to the decrease of corneal transparency, which seriously affects visual acuity. In addition, CNV can destroy the normal corneal microenvironment and make the physiological immune immunity of the anterior segment disappear. As a high risk factor for corneal graft rejection, the treatment of corneal neovascularization has become a hot topic in ophthalmology. Recent studies have confirmed that angiostatin (AS) has a definite anti-angiogenesis effect on corneal neovascularization. Corneal epithelial cells have been shown to secrete angiostatin, but the cornea is damaged. In addition, angiostatin has been proved to inhibit corneal neovascularization by viral vectors or local application. However, the lack of research on the mechanism of action affects the clinical application of angiostatin. Therefore, clarifying the mechanism of angiostatin against corneal neovascularization is bound to lay a solid foundation for its clinical application. The foundation and generate huge social and economic benefits.
2. research methods
As we all know, proteins are a kind of important biological macromolecules and the main undertakers of life activities. Since the concept of proteome was put forward, the research of proteomics has made gratifying progress. With the development of related experimental techniques, it is possible to study the similarities and differences of protein expression in different physiological or pathological conditions, the classification and identification of related proteins, especially the interaction between proteins and the function of proteins. Based on corneal neovascularization prepared by alkali burn, local angiostatin is applied to separate the protein and dye the cornea by two-dimensional electrophoresis. The gel image analysis system is used to quantitatively analyze the protein spots, so as to identify the differential expression of local angiostatin in the process of corneal neovascularization. Further, mass spectrometry was carried out to obtain qualitative data of related proteins.
3. research contents and process
(1) Experimental animals and groups: 32 New Zealand white rabbits (purchased from the Animal Center of Southern Medical University) were divided into three groups. Group A was the blank control group: 8 New Zealand rabbits did not do any treatment; Group B was the burned group: 12 New Zealand rabbits were used to establish corneal neovascularization model by alkali burns, the first one after operation. In group C, 12 New Zealand rabbits were treated with the same method to establish corneal neovascularization model, and 30 ug/ml angiostatin (AS) was used locally on the first day after operation, three times a day until corneal specimens were taken.
(2) Corneal neovascularization model: Corneal neovascularization model was prepared by alkali burn: Ketamine 25mg/kg and chlorpromazine 25mg/kg were injected intramuscularly into New Zealand rabbits for general anesthesia, 0.5% tetracaine for surface anesthesia, eyelid opener was placed to fully expose the ocular surface, 10 mm circular filter paper immersed in 1.5 mol/L NaOH solution was placed in the center of the ocular surface, and removed 1.5 minutes later, 50 M1 physiology was used. Rinse the eyedrop with saline and smear Tobramycin Eye Ointment with tobramycin eye drops.
(3) Observation of corneal neovascularization: observation of corneal neovascularization after surgery, the use of slit lamp (Suzhou 66 production YZ5T model) photography on the 16th. Corneal neovascularization detection: measurement of the length of blood vessels, small continuous curvature, neovascularization toward the center of corneal opacity growth of the longest blood vessels, and calculation of corneal neovascularization growth area (A) According to the formula A=C/12*3.1416[r2-(r-1)2], C is the number of circular clock points of Nv involved cornea, 1 is the length of neovascularization penetrating cornea from corneal limbus, and R is the radius of rabbit cornea.
(4) Sample sampling and whole protein extraction: 3 weeks after operation, the samples were quickly placed in a 5 ml cryopreservation tube, then stored in a cryopreserve refrigerator at - 80 C after liquid nitrogen freezing. The tissue blocks stored at - 80 C were quickly ground to a fine powder, then added lysate homogenate and centrifuged. The protein concentration of the samples was calculated by Bradford quantitative method.
(6) two dimensional gel electrophoresis (2-DE): first direction (IPG-IEF) isoelectric focusing was performed according to the isoelectric point of protein, and second directions (SDSPAGE) were separated according to the relative molecular weight of protein, and then stained with EMBL silver after two dimensional electrophoresis.
(7) image analysis and differential protein selection: scanning the silver stained 2-DE glue map into the computer. Each gel image was analyzed by ImageMaster2D software, and the relative protein content of all protein spots in the map was calculated to find out the protein that appeared in all three pieces of gum.
(8) Mass spectrometry analysis: the different protein spots were cut, decolorized, enzymatically hydrolyzed and extracted. The samples were analyzed by mass spectrometry using ABI 4700 MALDI-TOF-TOF mass spectrometer. The UV wavelength was 355 nm, the repetition rate was 200 HZ, the acceleration voltage was 200 000 V, the optimal mass resolution was 1500 Da. The scanning mass range was 700-3200 Da, and the signal was collected. The mass spectra of all the experimental samples were obtained by default mode.
(9) Database retrieval: Mascot distiller is used to filter baseline peaks and identify signal peaks. Matrixscience's Mascot software is used to search mammalian databases for matching proteins and query their functions to determine which proteins are identified. The error range between the apparent PI and the apparent MR is unlimited. (3) The maximum allowable error of the molecular weight of the peptide fragment is controlled at (+50 ppm.) (4) The incomplete selection of the enzymatic fragment is 1-2. (5) Species Source Selection (Mammal). (6) Ion Selection MH and monoisotopic. (7) Fixed modification to cysteine iodoacetamidation (Carbamidomethy1) can be changed to methionine. Oxidation (Oxsidation).
4. main results
(1) successful establishment of rabbit corneal neovascularization model.
(2) On the 16th day after corneal alkali burn, the area of neovascularization in angiostatin group (group C) was 37.62+9.65 mm2, and that in control group (group B) was 46.77+8.98 mm2. Two independent samples t test was used and SPSS 13.0 software was used to analyze the results. The results showed that angiostatin had inhibitory effect on corneal neovascularization.
(3) after two dimensional electrophoresis, A and C two groups were compared with B group, and 13 differential protein spots were detected.
(4) Differential protein identification: 13 proteins were identified by mass spectrometry and database searching. Among them, 6 proteins were significantly lower in group B than in group A and C: albumin precursor, heat shock protein A8, pyruvate kinase, beta B3-crystallin, retinal protein 1 and one not yet identified. Named proteins; group B was significantly higher than group A and C in six proteins: reticulum calcium binding protein 3, keratin 14, actin 11, immunoglobulin lambda chain, immunoglobulin K chain, binding globin.
5. main conclusions
In the past few decades, anti-angiogenic therapy has developed dramatically in tumor, corneal neovascularization and other neovascular diseases by local use or gene delivery. In this experiment, we found that the corneal neovascularization in alkali-burned rabbits decreased significantly after topical drip of angiostatin. In order to understand the mechanism of angiostatin's anti-angiogenic effect, we found that angiostatin could inhibit the elevated proteins such as keratin 14, reticulin 3 and nodule after alkali burn in cornea. Angiostatin also restores reduced proteins such as crystallin, retinol binding protein, albumin precursor, pyruvate kinase, and HSPA8, which are involved in corneal epithelial repair, energy metabolism, and protein synthesis. The dynamic change of protein content is the direction of our research.
【學(xué)位授予單位】：南方醫(yī)科大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2012
【分類號】：R772.2

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 解孝鋒,畢宏生;血管抑素治療眼部新生血管疾病研究進(jìn)展[J];山東醫(yī)藥;2004年20期

2 朱偉;陶祥臣;李新;袁中芳;牟國營;;內(nèi)皮抑素的低分子肝素修飾及對兔角膜新生血管的抑制作用[J];山東大學(xué)耳鼻喉眼學(xué)報(bào);2007年05期

3 解玉軍;高曉唯;李文靜;;1,25二羥基維生素D_3對兔角膜堿燒傷朗格罕氏細(xì)胞影響[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2011年05期

4 徐錦堂;陳建蘇;;角膜堿燒傷病理過程中的免疫機(jī)制[J];眼科新進(jìn)展;2007年04期

5 魏海霞;魯建華;張文芳;;吡格列酮對大鼠堿燒傷角膜IL-1α、IL-6表達(dá)的影響[J];眼科研究;2008年11期

6 劉春民,徐錦堂,趙松濱;角膜堿燒傷后機(jī)體巨噬細(xì)胞和淋巴細(xì)胞的功能變化[J];國際眼科雜志;2002年04期

7 鄭曉汾;綜述;褚仁遠(yuǎn);馮克孝;;角膜堿燒傷的免疫學(xué)研究[J];中國眼耳鼻喉科雜志;2004年05期

8 解玉軍;高曉唯;;角膜堿燒傷免疫學(xué)機(jī)制研究進(jìn)展[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2010年08期

9 皮裕t ;陸江陽;唐維強(qiáng);董瑩;;組織工程角膜上皮移植治療兔角膜堿燒傷的形態(tài)學(xué)觀察[J];國際眼科雜志;2008年11期

10 吳紅,張濼;角膜堿燒傷中郎格罕細(xì)胞的變化及作用[J];眼外傷職業(yè)眼病雜志(附眼科手術(shù));1992年S1期

相關(guān)會議論文 前10條

1 彭建軍;吳陽;胡大一;路璐;朱正炎;王長華;李建勇;郁鵬;;骨髓動員與骨髓細(xì)胞移植對急性心肌梗死豬再灌注后心肌修復(fù)及血管再生作用的比較研究[A];中華醫(yī)學(xué)會心血管病分會第八次全國心血管病學(xué)術(shù)會議匯編[C];2004年

2 陳奇;陳雪梅;劉秋瓊;陳松海;;復(fù)方姜黃合劑對糖尿病大鼠視網(wǎng)膜新生血管形成的干預(yù)[A];2010年廣東省藥師周大會論文集[C];2011年

3 銀華;;新生血管性青光眼患者的預(yù)防和護(hù)理[A];全國五官科護(hù)理學(xué)術(shù)交流暨專題講座會議論文匯編[C];2005年

4 陳濱;柏林;馬慶杰;;電離輻射對大鼠角膜堿燒傷所致新生血管形成的抑制作用[A];中華醫(yī)學(xué)會第九次全國核醫(yī)學(xué)學(xué)術(shù)會議論文摘要匯編[C];2011年

5 黃品同;黃福光;孫海燕;田新橋;楊琰;呂夕明;唐疾飛;張超;;超聲造影對頸動脈粥樣斑塊內(nèi)新生血管的血流動力學(xué)研究[A];2006年浙江省超聲醫(yī)學(xué)學(xué)術(shù)年會論文匯編[C];2006年

6 田孝祥;韓雅玲;康建;徐凱;閆承慧;;小鼠胚胎干細(xì)胞體外分化形成新生血管的實(shí)驗(yàn)研究[A];中華醫(yī)學(xué)會心血管病學(xué)分會第八次全國心血管病學(xué)術(shù)會議匯編[C];2006年

7 李世宏;葉劍;賀翔鴿;李翔驥;;Avastin結(jié)膜下注射治療角膜新生血管一例[A];中國眼底病論壇·全國眼底病專題學(xué)術(shù)研討會論文匯編[C];2008年

8 孫化萍;王育良;章淑華;王友法;陸綿綿;魏偉;;眼底新生血管與中醫(yī)辨證的相關(guān)性研究[A];全國第九次中醫(yī)、中西醫(yī)結(jié)合眼科學(xué)術(shù)年會論文匯編[C];2010年

9 鄭元義;王志剛;冉海濤;張群霞;李曉東;凌智瑜;盧岷;任紅;;超聲微泡造影劑對新生血管的作用[A];慶祝中國超聲醫(yī)學(xué)工程學(xué)會成立20周年——第八屆全國超聲醫(yī)學(xué)學(xué)術(shù)會議論文匯編[C];2004年

10 陳麗敏;康曉星;王華;邱麗穎;馮磊;金堅(jiān);;合歡皮不同路線提取皂苷對小鼠移植瘤的影響[A];中國藥理學(xué)會第十次全國學(xué)術(shù)會議專刊[C];2009年

相關(guān)重要報(bào)紙文章 前10條

1 阿勝;抑制新生血管 挽救患者視力[N];醫(yī)藥經(jīng)濟(jì)報(bào);2002年

2 侯潔;新生血管性青光眼如何治療？[N];健康時(shí)報(bào);2007年

3 劉侃;“卡特消”抑制腫瘤新生血管理論的實(shí)踐[N];科技日報(bào);2004年

4 高原;有點(diǎn)神奇,海藻中分離出強(qiáng)抗癌物質(zhì)[N];新華每日電訊;2008年

5 ;繼發(fā)新生血管性青光眼的治療[N];保健時(shí)報(bào);2005年

6 朱國旺;濕性黃斑變性的治療獲突破性進(jìn)展[N];中國醫(yī)藥報(bào);2008年

7 王丹;眼花了……[N];醫(yī)藥經(jīng)濟(jì)報(bào);2008年

8 王偉;我國新添治療脈絡(luò)膜新生血管眼科新藥[N];中國勞動保障報(bào);2005年

9 副主任醫(yī)師 馮春;如何預(yù)防糖尿病性視網(wǎng)膜病變[N];衛(wèi)生與生活報(bào);2007年

10 ;糖尿病視網(wǎng)膜病變分期[N];保健時(shí)報(bào);2005年

相關(guān)博士學(xué)位論文 前10條

1 李燕偉;人羊膜間充質(zhì)干細(xì)胞移植對兔角膜堿燒傷的療效及磁標(biāo)記示蹤分析[D];鄭州大學(xué);2013年

2 陳鵬;角膜血管膜上皮細(xì)胞表型鑒定及新生血管相關(guān)靶點(diǎn)的篩選[D];青島大學(xué);2012年

3 邱培瑾;角膜堿燒傷后新生血管增殖的實(shí)驗(yàn)研究[D];浙江大學(xué);2002年

4 吳利安;異基因骨髓間充質(zhì)干細(xì)胞早期局部移植修復(fù)堿燒傷角膜的研究[D];天津醫(yī)科大學(xué);2008年

5 鄭凱;Angiostatin對膀胱腫瘤新生血管抑制作用的實(shí)驗(yàn)研究[D];第四軍醫(yī)大學(xué);2004年

6 石文靜;吸氧和血管生長因子在新生小鼠視網(wǎng)膜病發(fā)病中的作用[D];復(fù)旦大學(xué);2004年

7 陶開山;血管抑素抗腫瘤血管生成機(jī)制的實(shí)驗(yàn)研究[D];第四軍醫(yī)大學(xué);2004年

8 姚兵;Tumstatin基因的克隆、表達(dá)及其與吉西他濱聯(lián)合抗腫瘤作用的實(shí)驗(yàn)研究[D];四川大學(xué);2005年

9 姜荔;視網(wǎng)膜色素上皮形態(tài)學(xué)改變對脈絡(luò)膜新生血管臨床轉(zhuǎn)歸的影響[D];中國人民解放軍軍醫(yī)進(jìn)修學(xué)院;2004年

10 包大士;重組腺病毒載體介導(dǎo)血管抑素基因治療大鼠腦膠質(zhì)瘤的實(shí)驗(yàn)研究[D];蘇州大學(xué);2001年

相關(guān)碩士學(xué)位論文 前10條

1 徐懿;Akt促進(jìn)大鼠角膜新生血管形成的初步研究[D];中南大學(xué);2012年

2 左進(jìn)彩;地塞米松聯(lián)合羊膜勻漿上清液治療兔角膜堿燒傷的實(shí)驗(yàn)研究[D];山西醫(yī)科大學(xué);2010年

3 幸正茂;他可莫司滴眼液治療角膜堿燒傷的免疫學(xué)機(jī)制研究[D];南昌大學(xué);2010年

4 陳小雄;胰島素對兔角膜堿燒傷早期組織病理學(xué)與白介素表達(dá)的影響[D];重慶醫(yī)科大學(xué);2010年

5 李靜;維生素C不同頻率及途徑對兔角膜堿燒傷療效觀察[D];山西醫(yī)科大學(xué);2011年

6 唐霞;胰島素在兔角膜堿燒傷后抗凋亡作用的初步研究[D];重慶醫(yī)科大學(xué);2010年

7 楊杰;綠茶多酚對小鼠角膜堿燒傷的治療作用研究[D];浙江大學(xué);2012年

8 董瑩;雷帕霉素抑制大鼠角膜移植排斥和新生血管的實(shí)驗(yàn)研究[D];中國人民解放軍軍醫(yī)進(jìn)修學(xué)院;2004年

9 顧朝輝;玻璃體后脫離對光凝治療糖尿病視網(wǎng)膜病變效果影響的臨床研究[D];河北醫(yī)科大學(xué);2005年

10 徐為海;金雀異黃素對兔角膜堿燒傷新生血管的抑制作用研究[D];南京醫(yī)科大學(xué);2009年

，

本文編號：2245466